Fund Mojo help you discover the best fund managers, funds, and related information

Fund Intelligence | Best Managers | FBIOX Insights | FBIOX Score | FBIOX Performance | FBIOX News | FBIOX Allocation | FBIOX Holdings Change

Fidelity Select Biotechnology Portfolio (FBIOX) Fund Ranking and Research

Ranking, Research and Recommendation of Fidelity Select Biotechnology Portfolio (FBIOX) Fund

    Last Trade: $188.68 on 7/29/2016, Change: +0.63 (0.34%)

 

Graph of Fidelity Select Biotechnology Portfolio Fund (FBIOX) ManagerFund Manager - Rajiv Kaul

Fund Manager Information

Fund Manager Tenure: 10.8 years
Fund Family: Fidelity Investments
Fund Category: Health
Fund Performance: May 30, 2016
Fundmojo Fund Grade: B (Score: 0.68)     (What does this score mean?)
Kaul is a portfolio manager with Fidelity Investments. Since joining Fidelity Investments in 1996, he has worked as a research analyst and portfolio manager. Kaul also manages another Fidelity fund. He is the recipient of the Kann Rasmusson Environment Award, the Dean's Summer Research Award and a Ford Undergraduate Fellowship.  Get more insights on Rajiv Kaul

 

Graph of Fidelity Select Biotechnology Portfolio Fund (FBIOX) ProfileFidelity Select Biotechnology Portfolio Fund (FBIOX) Profile

Fund Profile and Description

Fidelity Select Biotechnology Portfolio Fund seeks capital appreciation. Fidelity Select Biotechnology Portfolio Fund normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes and companies that benefit significantly from scientific and technological advances in biotechnology. These companies may include, companies involved in the research, development, or production of pharmaceuticals, including veterinary drugs. It may invest in securities of foreign issuers. Fidelity Select Biotechnology Portfolio Fund is non-diversified.

 

Fidelity Select Biotechnology Portfolio (FBIOX) Fund Strength What we like about Fidelity Select Biotechnology Portfolio (FBIOX) Fund

Data for Fidelity Select Biotechnology Portfolio Fund (FBIOX) as of May 30, 2016

  • Fidelity Select Biotechnology Portfolio Fund (FBIOX) management has been with Fidelity Select Biotechnology Portfolio Fund for 10.8 years
  • Fidelity Select Biotechnology Portfolio Fund (FBIOX) has good mid-term performance (3-year return 15.59% vs 15.21% Health category median performance)
  • Fidelity Select Biotechnology Portfolio Fund (FBIOX) has good Long-term performance (5-year return 22.26% vs 16.08% Health category median performance)
  • Fidelity Select Biotechnology Portfolio Fund (FBIOX) ratio of up-years vs down years is greater than 2
  • Asset base in Fidelity Select Biotechnology Portfolio Fund (FBIOX) has been consistently increasing at a reasonable pace in the last 2 months. It shows investor confidence and market support
  • Fidelity Select Biotechnology Portfolio Fund (FBIOX) has an annual stock turnover rate of 35.00% vs Health average of 43.99%. It is good that Fidelity Select Biotechnology Portfolio management does not trade extensively for its return.
  • Fidelity Select Biotechnology Portfolio Fund (FBIOX) has a lower expense ratio than its Health average: 0.73% vs 1.32%
  • Fidelity Select Biotechnology Portfolio Fund (FBIOX) is a true no-load fund as it has no load and no 12b1 promotion, distributions, marketing expenses

Fidelity Select Biotechnology Portfolio Fund (FBIOX) Weakness What we are cautious about Fidelity Select Biotechnology Portfolio (FBIOX) Fund

Data for Fidelity Select Biotechnology Portfolio Fund (FBIOX) as of May 30, 2016

  • Fidelity Select Biotechnology Portfolio Fund (FBIOX) has a less-than-ideal short-term performance (1-year return -24.99% vs -12.93% Health category median performance)
  • Fidelity Select Biotechnology Portfolio Fund (FBIOX) has a Morningstar rating of 3 and below
  • Fidelity Select Biotechnology Portfolio Fund (FBIOX) is less safe compared to its Health peers
  • Fidelity Select Biotechnology Portfolio Fund (FBIOX) is more volatile than its peers as it has a 3-year Standard Deviation of 29.78 that is higher than category average of 17.59
  • As a Health focused fund, Fidelity Select Biotechnology Portfolio Fund (FBIOX) is less diversified and has inherited sector risks associated with the fund
See Fidelity Select Biotechnology Portfolio Fund (FBIOX) performance details as of May 30, 2016

 

What do you think?

 

Compare Fidelity Select Biotechnology Portfolio Fund (FBIOX)Compare with other top Health category mutual funds

Aadditional top Health mutual funds for your consideration

FundYear to Date1 Year3 year5 year
Fidelity Select Biotechnology Portfolio-19.19-24.9915.5922.26
Hartford Healthcare A (HGHAX)-6.82-7.8017.3816.39Compare
Janus Global Life Sciences T (JAGLX)-7.78-15.8319.3919.37Compare
AllianzGI Health Sciences A (RAGHX)-4.62-9.3315.8113.50Compare

See top fund managers for Health Category Funds

 

Compare Fidelity Select Biotechnology Portfolio Fund (FBIOX)Compare with Health category ETFs

Some Health ETFs for your consideration

ETFYear to DateOne YearThree Year
First Trust NYSE Arca Biotech ETF (FBT)000
SPDR S&P Health Care Equipment ETF (XHE)000
SPDR S&P Biotech ETF (XBI)000
PowerShares S&P SmallCap Health Care ETF (PSCH)000
PowerShares Dynamic Pharmaceuticals ETF (PJP)000

 

Graph of Fidelity Select Biotechnology Portfolio Fund (FBIOX) Net Asset TrackingFidelity Select Biotechnology Portfolio (FBIOX) Fund Net Asset

Track net asset change of Fidelity Select Biotechnology Portfolio fund (FBIOX)

DateNet Asset
05/2016$10.91B
03/2016$9.96B
02/2016$9.73B
More historic net asset information on Fidelity Select Biotechnology Portfolio Fund (FBIOX)

  

Graph of Fidelity Select Biotechnology Portfolio Fund (FBIOX) Portfolio TrackingFidelity Select Biotechnology Portfolio (FBIOX) Fund Portfolio Allocation

Track portfolio allocation change of Fidelity Select Biotechnology Portfolio fund (FBIOX)

DateCashStockBondOther
04/20160.6%99.36%0%0%
02/20161.21%98.75%0%0%
01/20160.04%99.96%0%0%
Click here to see more historic asset allocation information on Fidelity Select Biotechnology Portfolio Fund (FBIOX)

 

graph of Fidelity Select Biotechnology Portfolio Fund (FBIOX) Top 10 Position TrackingTop 10 Holdings in Fidelity Select Biotechnology Portfolio (FBIOX) Fund

Discover what Fidelity Select Biotechnology Portfolio Fund (FBIOX) manager is buying

Apr 29, 2016
Regeneron Pharmaceuticals, Inc. [6.83%]
Alexion Pharmaceuticals, Inc. [5.15%]
Celgene Corporation [4.38%]
Biogen Inc. [4.03%]
Vertex Pharmaceuticals Incorpor [3.95%]
BioMarin Pharmaceutical Inc. [3.78%]
Medivation, Inc. [3.16%]
Gilead Sciences, Inc. [2.85%]
Incyte Corporation [2.46%]
GENMAB A/S DKK [1.97%]

Feb 28, 2016
Alexion Pharmaceuticals, Inc. [5.59%]
Regeneron Pharmaceuticals, Inc. [5%]
Vertex Pharmaceuticals Incorpor [4.24%]
BioMarin Pharmaceutical Inc. [3.88%]
Celgene Corporation [3.56%]
Biogen Inc. [3.48%]
Incyte Corporation [3.01%]
GENMAB A/S DKK [2.69%]
Medivation, Inc. [2.62%]
Gilead Sciences, Inc. [2.16%]

Jan 30, 2016
Alexion Pharmaceuticals, Inc. [5.79%]
Vertex Pharmaceuticals Incorpor [4.34%]
Regeneron Pharmaceuticals, Inc. [4.16%]
Celgene Corporation [3.88%]
Biogen Inc. [3.8%]
BioMarin Pharmaceutical Inc. [3.51%]
GENMAB A/S DKK [2.98%]
Incyte Corporation [2.86%]
Medivation, Inc. [2.21%]
Gilead Sciences, Inc. [2.2%]
Click here for Stock Holding Change Map in Fidelity Select Biotechnology Portfolio Fund (FBIOX)

  

Latest News on Fidelity Select Biotechnology Portfolio (FBIOX) Fund

See what is happening with Fidelity Select Biotechnology Portfolio Fund (FBIOX)

 

Fidelity Select Biotechnology Portfolio Fund (FBIOX) Related ResourcesSee more information on Fidelity Select Biotechnology Portfolio (FBIOX) Fund

Popular pages on Fidelity Select Biotechnology Portfolio (FBIOX) Fund

  

Fund Mojo Newsletter

Fund Mojo on Facebook Follow FundMojo on Twitter Fund Update